Actinide is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Actinide is the first private company to enrich uranium to HALEU (19.75% U-235) using modernized Calutron (electromagnetic isotope separation) technology, initially selling medical isotopes at $30k/gram while scaling for advanced reactor fuel — a category-creating domestic supply chain play.